Evidence map›Paper›PMID 12695330›Full record

ArticleGenome research2003

Exo-proofreading, a versatile SNP scoring technology.

Patrick Cahill, Michele Bakis, James Hurley, Veena Kamath, William Nielsen, Dina Weymouth, Josee Dupuis, Lynn Doucette-Stamm, Douglas R Smith

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Genome research, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 15 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Patrick CahillGenome Therapeutics Corporation, Waltham, Massachusetts 02453, USA. pcahill@genomecorp.com
Michele Bakis
James Hurley
Veena Kamath
William Nielsen
Dina Weymouth
Josee Dupuis
Lynn Doucette-Stamm
Douglas R Smith
NKT Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the validation of a new assay for typing single nucleotide polymorphisms (SNPs) that takes advantage of the 3'-to-5' exonuclease proofreading activity of many DNA polymerases. The assay uses one or more primers labeled on the 3' nucleotide base, and can be implemented in a variety of formats including a one-step PCR reaction that allows SNP typing directly from genomic DNA samples. The detection of genotypes can be accomplished by means of fluorescence detection on assays that have been purified to remove excess primer, or by means of fluorescence polarization without any additional cleanup. We also demonstrate that the Exo-Proofreading SNP assay can be used on pooled samples to obtain allele frequency data.

Indexed as

AllelesDNA-Directed DNA PolymeraseDNA Mutational AnalysisGene FrequencyHumansPolymorphism, Single NucleotideSequence Analysis, DNADNA-Directed DNA PolymerasePwo polymerase

Identifiers

PMID12695330
PMCPMC430895
OpenAlexW1972564740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.